Pharmaceutical Technology
March 02, 2010
Issue PDF
33
3
In Search of a Sterile Fill
March 19, 2009
Online Exclusives
33
3
Instead of protecting the public from unsafe drugs and contaminated foods, the Food and Drug Administration is a "hazard to public health," stated President Barack Obama in announcing his choices to head the agency and new efforts to improve food safety. Margaret Hamburg will be FDA's new commissioner, and Joshua Sharfstein principal deputy commissioner for drugs and medical products.
March 02, 2009
News
33
3
Scientists studying epilepsy have traditionally focused on the comings and goings of ions through molecular channels in nerve cells, and many current antiseizure therapies seek to modulate that dynamic.
March 02, 2009
Peer-Reviewed Research
33
3
Ultra high performance liquid chromatography is advantageous in a contract laboratory because it is faster, more sensitive, and relies on smaller volumes of organic solvents than HPLC.
March 02, 2009
Inside USP
33
3
USP's Stage 2 heparin monograph revisions address identification, potency, and impurities.
March 02, 2009
Viewpoint
33
3
USP's revised chapter on injectables could harm anticounterfeiting efforts and drug administration.
March 02, 2009
Peer-Reviewed Research
33
3
The authors investigate the effects of a polyethylene glycol plasticizer and water on cellulose acetate film properties.
March 02, 2009
Washington Report
33
3
Broader disclosure of drug prices and conflicts of interest are central healthcare reform issues.
March 02, 2009
Guest Editorial
33
3
Industry has changed, but its basic tenets have not. INTERPHEX's RJ Palermo discusses a 7-step process to keep pharma moving forward.
March 02, 2009
Peer-Reviewed Research
33
3
The authors extend the range of a near-infrared calibration model for tablet assay using production 'seed' spectra and synthetic spectra generated from placebos and 'pure' active pharmaceutical ingredient spectra.
March 02, 2009
Agent-In-Place
33
3
The source of a problem reveals itself after some investigation, or it may crash down on you.
March 02, 2009
Outsourcing Outlook
33
3
When the business environment returns to "normal," our industry may appear quite different.
March 02, 2009
Special Report
33
3
Small- and large-molecule drugmakers debate whether they can replicate other industries' success with just-in-time manufacturing.
March 02, 2009
In the Spotlight
33
3
Editors' Picks of Pharmaceutical Science & Technology Innovations
March 02, 2009
PharmTech Talk
33
3
Contract manufacturers of APIs and intermediates report gains, but express caution.
March 02, 2009
Ingredients Insider
33
3
Contract manufacturers deploy a business model using operations in the US and Western Europe with facilities in Asia.
March 02, 2009
Packaging Forum
33
3
Integrated lines, flexible machines, and high-barrier materials enhance packaging options.
March 02, 2009
Peer-Reviewed Research
33
3
The author tests the ruggedness of VRL viewing conditions and defines optimal viewing conditions.
March 02, 2009
Online Exclusive
33
3
An updated book provides essential information for scientists who monitor microbial quality.
March 02, 2009
Special Report
33
3
Pharmaceutical Technology's annual survey on equipment and machinery shows fewer companies increased spending in 2008 and still fewer will increase spending in 2009 as overall economic conditions affects purchasing decisions.
March 02, 2009
Peer-Reviewed Research
33
3
The authors present a simple and material-sparing approach for estimating the powder-flow performance of previously uncharacterized single-component bulk powders when only particle-size distribution data are available.
March 02, 2009
News
33
3
With the economy down and multinational firms capitalizing on patents in developing countries, India's R&D sector still has a long way to grow.